miDiagnostics

Foundation date

28-10-2015

Sector

#Medical Technology

Subsector

miDiagnostics wants to bring miniaturized, rapid, easy-to-use, lab-quality tests with built in connectivity direct to the patient and clinician.

To do this, we are working to transform attitudes to diagnostic testing, currently dominated by centralised laboratory testing, and provide accurate and integrated disease analysis, enabling rapid access to lab-quality diagnostic information for everyone, anywhere and anytime.

Upcoming events

Latest news

  • SeptiCyte® RAPID receives 510(k) clearance by US FDA

    Wednesday December 1st 2021

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    Wednesday December 1st 2021

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    Wednesday December 1st 2021

Jobs by miDiagnostics